2. Lymphedema prospective surveillance and risk reduction
Lymphedema prospective surveillance and risk reduction
In this session, Dr. Shallwani will examine prospective surveillance and risk reduction approaches in lymphedema. She will present the latest research evidence on these approaches and share examples of two Canadian programs. She will also discuss practical challenges to integrating prospective surveillance, and propose potential solutions based on research findings and clinical experience.
Following this presentation, participants will be able to:
1. Understand the principal components of the prospective surveillance model
2. Identify potential lymphedema risk reduction practices (non-surgical)
3. Be familiar with recent research on lymphedema prospective surveillance and risk reduction
4. Recognize potential challenges and solutions to implementing prospective surveillance for lymphedema
